GEELONG, Australia, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that it has reached agreement with Orion Infrastructure Capital (“OIC”) to provide a further up to US$7 million of funding. The Company also reports the cancellation of two electric vehicle (“EV”) wheel programs, which is consistent with the weakening of demand a ...

融资完成情况 - 公司完成先前宣布的包销私募发行 单位发行量为69445万单位 每单位价格为144加元 募集资金总额为1亿加元 同时发行7944万流转股 每股价格为158加元 募集资金总额为12551520加元 [1] - 每单位包含一股普通股和一份认股权证 每份权证可于2027年10月31日前以192加元的行权价认购一股普通股 若自2027年1月31日起 公司普通股在TSX创业交易所的收盘价连续20个交易日超过行权价 公司有权在10天内通知权证持有人将到期日加速至通知日期后30天 [1] 承销商与佣金 - 本次发行由National Bank Financial Inc领衔 包括BMO Capital Markets和Red Cloud Securities Inc 承销商获得相当于发行总收益50%的现金佣金 但向特定总裁名单买家出售的1000万加元单位部分佣金率为25% [2] 资金用途 - 单位发行的净收益将用于资助Goldboro露天金矿开发项目的相关支出以及一般公司运营和营运资金需求 流转股发行的总收益将用于在2026年12月31日前产生符合加拿大所得税法定义的"加拿大勘探支出" 即"流转采矿支出" [3] 内部人士参与 - 公司内部人士认购了2875万单位 总额为414万加元 以及178万流转股 总额为28124万加元 每位内部人士的认购构成多边文书61-101下的"关联方交易" 公司未在发行截止日前21天提交重大变更报告 因发行细节和关联方参与情况直至发行截止前不久才确定 且公司出于合理商业原因希望加速完成发行 [5] 公司项目资产 - 公司是一家专注于黄金的企业 在加拿大和阿拉斯加拥有资产 Goldboro金矿项目位于新斯科舍省 Goliath黄金综合体位于安大略省西北部 公司还拥有其他项目 包括Weebigee-Sandy Lake黄金项目合资企业和草根黄金勘探资产Gold Rock 此外 公司100%控股位于阿拉斯加东南部的高品位Niblack铜-金-锌-银VMS项目 [7]

BROAD ARROW, A HAGERTY COMPANY, ESTABLISHES EXCLUSIVE NORTHEAST PRESENCE AS AUDRAIN SOLIDIFIES POSITION AS REGION'S PREMIER AUTOMOTIVE DESTINATION A snapshot of the 2025 Audrain Newport Concours, which will feature Broad Arrow as exclusive auction partner beginning in 2026. Credit - Francesca Dolnier / Courtesy of Audrain Newport Concours & Motor Week A snapshot of the 2025 Audrain Newport Concours, which will feature Broad Arrow as exclusive auction partner beginning in 2026. Credit - Francesca Dolni ...

公司财务与活动安排 - 公司将于2025年11月10日美股市场收盘后发布2025年第三季度财务业绩 [1] - 管理层将于2025年11月10日东部时间下午4:30举行网络直播和电话会议 [1] 公司业务与产品管线 - 公司是一家专注于开发针对罕见病的变革性细胞和基于外泌体疗法的生物技术公司 [2] - 公司的主要候选产品Deramiocel是一种同种异体心脏来源的细胞疗法 目前正处于治疗杜氏肌营养不良症的后期临床开发阶段 [2] - 临床前和临床数据表明Deramiocel具有强大的免疫调节和抗纤维化作用 有助于保留DMD患者的心肌和骨骼肌功能 [2] - 公司正利用其专有的StealthX™外泌体技术平台进行临床前开发 专注于疫苗学以及寡核苷酸、蛋白质和小分子疗法的靶向递送 [2] 商业合作与监管状态 - 公司已与日本新药株式会社就Deramiocel在美国和日本用于DMD的独家商业化和分销达成协议 该协议需经监管批准 [5] - Deramiocel和StealthX™疫苗均为研究性候选产品 尚未在任何适应症中获准商业使用 [5]

Order strengthens growing partnership to deploy long-duration energy storage across multiple marketsPITTSBURGH, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) and Frontier Power Ltd. (“Frontier”), a leading UK-based energy developer, today announced a strategic 228 megawatt-hour (MWh) order to deplo ...

On 31 October 2025 the Annual General Meeting of Shareholders of AB Akola Group approved the consolidated and the Company’s Financial Statements, consolidated Management Report, the Independent Practitioners’ Limited Assurance Report on AB Akola Group consolidated Sustainability Report, and Independent Auditor's Report on the Company’s consolidated Financial Statements for the financial year ended 30 June 2025. Key financial indicators Consolidated revenues of the subsidiaries of AB Akola Group (the Group) ...

Faster initial remission and response, persistent benefit over six monthsSALT LAKE CITY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that treatment informed by the GeneSight® test led to faster initial remission and response in patients with Major Depressive Disorder (MDD). Further, the post-hoc analysis showed ...

Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline. COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its third quarter 2025 financial results on Thursday November 6, 2025, before opening of the Nasdaq CM. Evaxion’s Executive Management will host a conference call and webcast the ...

A Media Snippet accompanying this announcement is available by clicking on this link. ABU DHABI, United Arab Emirates, Oct. 31, 2025 (GLOBE NEWSWIRE) -- SEGG Media Corporation (Nasdaq: SEGG, LTRYW) (“SEGG Media” or “the Company”), today announced that two Racing Women drivers will compete this weekend in Round 1 of the 2025/26 Gulf Radical Cup at Yas Marina Circuit marking another milestone in the company’s expanding influence across global motorsport and women’s racing. The SEGG Media and Sports.com team ...

New York, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Linkers Industries Limited (Nasdaq: LNKS) (the “Company”), a manufacturer and a supplier of wire/cable harnesses with operation in Malaysia, today announced closing of the transaction with LPW Electronics Co., Ltd. On October 16, 2025, Linkers Asia Pacific Limited (“Linkers Asia”), a wholly owned subsidiary of Linkers Industries Limited (the “Company”) entered into a Share Sale and Purchase Agreement (“SPA”), with Mr. Man Tak Lau, the chairman of the board of dire ...